等待开盘 04-02 09:30:00 美东时间
+0.040
+0.21%
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30
今日重点评级关注:花旗:维持Biomea Fusion"买入"评级,目标价从6美元升至7美元;Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.75美元升至8.25美元
03-30 11:49
Jefferies analyst Kaumil Gajrawala upgrades Primo Brands (NYSE:PRMB) from Hold to Buy and announces $25 price target.
03-27 22:56
今日重点评级关注:韦德布什:维持TScan Therapeutics"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持莱斯康制药"买入"评级,目标价从4美元升至6美元
03-06 11:58
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
Barclays analyst Lauren Lieberman maintains Primo Brands (NYSE:PRMB) with a Overweight and raises the price target from $21 to $27.
03-02 22:48
Tech stocks tumbled Thursday as investors sold the news following blockbuster results from Nvidia Corp. (NASDAQ:NVDA), dragging the broader semiconductor space lower despit
02-27 01:28
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
The earnings results for Primo Brands (NYSE:PRMB) for Q4 were made public on Th...
02-26 19:04